Prolymphocytic leukemia

From WikiMD.org
Jump to navigation Jump to search

Prolymphocytic leukemia (pronunciation: pro-lymph-o-cytic leu-ke-mia) is a type of cancer that affects the lymphocytes, a type of white blood cell in the immune system. It is characterized by the overproduction of immature lymphocytes, known as prolymphocytes, in the bone marrow, blood, and lymphoid tissues.

Etymology

The term "Prolymphocytic leukemia" is derived from the Greek words "pro" meaning "before", "lympho" referring to the clear fluid that circulates in the lymphatic system, and "cytic" meaning "cell". "Leukemia" is derived from the Greek words "leukos" meaning "white" and "haima" meaning "blood", referring to the high number of white blood cells found in individuals with the condition.

Types

There are two types of Prolymphocytic leukemia: T-cell Prolymphocytic Leukemia (T-PLL) and B-cell Prolymphocytic Leukemia (B-PLL). These types are named after the specific type of lymphocyte they affect.

Symptoms

Common symptoms of Prolymphocytic leukemia include fatigue, weight loss, fever, night sweats, and swollen lymph nodes.

Diagnosis

Diagnosis of Prolymphocytic leukemia typically involves blood tests, bone marrow biopsy, and genetic testing to identify abnormalities in the lymphocytes.

Treatment

Treatment options for Prolymphocytic leukemia may include chemotherapy, immunotherapy, stem cell transplant, and targeted therapy.

Prognosis

The prognosis for Prolymphocytic leukemia varies depending on the type (T-PLL or B-PLL), the patient's overall health, and the response to treatment.

See also

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski